History and Experience

Since 1974 and its creation by Dr. M.A. Charles, it has been the Diabetes Research Center's mission to improve patient care while working with manufacturers to advance the standards in diabetes medicine. Today, our Tustin-based center continues to be committed to serving front lines of diabetes research. Since its inception, the Diabetes Research Center has cared for over 10,000 patients and performed over 200 clinical studies.

  • Amgen
  • Astellas
  • BMS
  • Biodel
  • Boehringer
  • Cebix
  • Dainippon
  • Eisai
  • Eli Lilly
  • Forest
  • GSK
  • Gilead
  • Intarcia
  • Jansen
  • Johnson&Johnson
  • Lexicon
  • Lexicon
  • Mannkind
  • Merck
  • Mitsubishi
  • Mylan
  • Mylan
  • Novartis
  • NovoNordisk
  • Parke Davis
  • Pfizer
  • Roche
  • Sankyo
  • Sanofi
  • Schwarz
  • Syrrx
  • Takeda
  • DPP4 inhibitors, sGLT2
  • GLP1
  • Lipid lowering agents
  • Short and Long acting insulin analogs
  • anti-obesity agents
  • insulin delivery devices
  • neuropathy pain
  • neuropathy regeneration
  • oral hypoglycemic agents
These are many of the investigational studies DRC has conducted:
  1. ASTA Medica Nerve Trial Oral drug: Nathan, 1998-2004
  2. Amgen 10184 Nephropathy, 2004-2007
  3. Astellas 223 Neuropathy, 10/2005-06/2006
  4. Astellas local patch for DPN pain, 4/2012- 2013
  5. Astellas neuropathy pain 6/2015
  6. Astra Zeneca 002, 003, 006 11/2014-
  7. Aventis Apidra 3511 insulin, 08/2004-01/2006
  8. Aventis, France, CSII/lantus, 2002-2003
  9. BMS 102-030 dapagliflozin, 07/2008-12/2009
  10. BMS 114-006 Pain, 07/2008-01/2009
  11. BMS 73 and 77 antihypertensive, 7/2011- 2013
  12. BMS saxagliptin, 10/2005-11/2007
  13. Boehringer 1245.69 type 1 7/2015 -
  14. Bristol Myers Squibb, PPAR?, ? agonist, 2001-2003
  15. Cebix phase 1 neuroregenerator, 1/2012-8/2012
  16. Cebix phase 2 neuroregenerator, 12/2012- 2014
  17. Dainnippon 253 Neuropathy, 10/2004-08/2006
  18. Eisai 07 neuropathy, 09/2007-07/2008
  19. Eisai 291 Neuropathy, 07/2009-2012
  20. Eli Lilly GBDA, 02/2010-2011
  21. Eli Lilly LQBF Pain (IND # 103,029), 03/2009-2010
  22. Forest MD02 Pain, 02/2009-2010
  23. GSK 179 GLP1, 4/10/2011
  24. GSK 486 GLP1, 10/2009-2011
  25. GSK 754/755/757 GLP1, 03/2009-2013
  26. GSK 856 GLP1, 7/2011-11/12
  27. GSK 977 weekly albiglutide 1/2015-
  28. GSK CTT 855 COPD 2014-current
  29. GSK Nerve 10, 2003-2004
  30. GSK Nerve Pain 05 & 04, 2002-2004
  31. GSK Nerve Pain 06 Extension, 2003-2004
  32. GSK Renal & Avandia, 2002-2002
  33. Gilead oral agent, 8/2012- 2013
  34. Intarcia implantable GLP1, 03/2013- 2014
  35. Jansen Parexel new insulin 2014-2015
  36. Johnson and Johnson 2002 Pain, 10/2009-10/2009
  37. Johnson and Johnson 3015 Pain (IND # 61,345), 02/2008-08/2008
  38. KOS, Advicor Lipid Trial: Anthem, 2002-2003
  39. Lexicon sGLT2 in type 1 6/2015
  40. Lilly BIAJ long acting insulin, 2012- 2014
  41. Lilly BIAO, BIAM long acting insulin, 1/2012- 2014
  42. Lilly BIAX, BIAK long acting insulin, 3/2013- 2014
  43. Lilly EIBH Cholesterol 2014-current
  44. Lilly GBDI GLP1 7/2014-
  45. Lilly GLDI glucagon antagonist 3/2014-12/2014
  46. Lilly IOQC insulin, 12/10-12/12
  47. Lilly MBBP Nerve Mild, 2002-2004
  48. Lilly MBBP Nerve Pain, 2002-2004
  49. Lilly Nerve Pain Dulox, 2002-2004
  50. Mannkind 009 & 102 Inhaled Insulin, 04/2006-08/2008
  51. Mannkind 162 inhaled insulin, 9/10/2011
  52. Mannkind 171 and 175 inhaled insulin, 12/11/2013
  53. Memantine Nerve Pain Study, 2002-2003
  54. Merck 006 new basal insulin in type 2 4/2014-3/2015
  55. Merck 03 new basal insulin 2/2014- 2015
  56. Merck 20, 2003-2004
  1. Merck 22 gliptin 2/2014-11/2014
  2. Merck 24 new ADO 1/2013 - current
  3. Merck 25, 2002-2004
  4. Merck 30, 2003-2004
  5. Merck 431E DPP4, 6/2012- 2014
  6. Mitsubishi 03 04 Neuropathy, 05/2006-01/2008
  7. Mylan 001 new basal insulin in type 1 11/2014 -
  8. Mylan 002 new basal insulin in type 2 10/2014 -
  9. Novartis Diovan Kidney, 2002-2004
  10. Novartis HTN 2201, 2002-2004
  11. Novartis LAF Type 2 Oral Agent, 2002-2004
  12. Novartis LAF, GLP1 inh, 2301 Oral Agent, 04/2004-12/2005
  13. Novartis LAF, GLP1 inh, 2311 Oral Agent, 07/2004-10/2005
  14. Novartis Nerve Pain, Trileptal, 2002-2004
  15. Novartis, Starlix, 2001-2004
  16. Novo 3916 GLP1, 12/2012- 2014
  17. Novo Nordisk 1683 Inhaled Insulin, 02/2007-12/2007
  18. Novo Nordisk 1842, 06/2009-2011
  19. Novo Nordisk 1971 insulin pen, 10/2008-06/2009
  20. Novo Nordisk 3579/3582/3583 SIBA/SIAC Insulin, 09/2009-2012
  21. Novo Nordisk 3718 Insulin, 03/2010-2011
  22. NovoNordisk 1922 GLP1, 06/2011- 2013
  23. Pfizer 1089 Inhaled Insulin, 02/2007-05/2007
  24. Pfizer 1093 Inhaled Insulin, 06/2006-01/2007
  25. Pfizer A5351022 Obesity study, 05/2007-12/2008
  26. Pfizer CETP inhibitor 1018 Lipid, 08/2004-03/2005
  27. Pfizer Inhaled (111) Type 1&3 (PHASE 3), 1999-2003
  28. Pfizer Inhaled Insulin Type 2 (1022), 2000-2006
  29. Pfizer Inhaled Insulin Type 2 (1029), 2001-2006
  30. Pfizer Pregablin 1071 Neuropathy, 07/2005-02/2006
  31. Pfizer inhaled insulin 1002, 2002-2003
  32. Pfizer inhaled insulin 1028, 02/2004-01/2006
  33. Pfizer inhaled insulin 1030, 02/2004-04/2005
  34. Pfizer, CETP Inhibitor Lipid Study: 1017, 2000-2003
  35. Pfizer, CETP Inhibitor Lipid Study: 1026 Phase 2, 2000-2003
  36. Pfizer, CETP Inhibitor Lipid Study: 1027, 2002-2003
  37. Pfizer, Inhaled Insulin (Type 2) 1017, 2003-2007
  38. Pfizer, Inhaled Insulin Type 1 1027, 2000-2004
  39. Pfizer-Merck 1017 gliptin 10/ 2014 -
  40. Sankyo Nerve, 2003-2004
  41. Sanofi 1628 1629 long acting insulin, 12/2011- 2013
  42. Sanofi 347 and 456 long acting insulin, 10/2012- 2014
  43. Sanofi 403 new short acting insulin 2/2015 -
  44. Sanofi Aventis PDY5807 neuropathy, 09/2007-01/2009
  45. Sanofi-Aventis Lantus Type 2, 2001-2004
  46. Sanofi-Aventis Lantus Type 2, 2003-2005
  47. Schwarz 745 & 768 Neuropathy, 04/2005-04/2006
  48. Syrrx-Takeda 322 gliptin, 06/2009-2011
  49. Syrxx 003 Oral Agent, 05/2005-09/2005
  50. Syrxx 011 & 012 Oral Agent, 10/2005-01/2007
  51. Takeda 128 003 & 006 Neuropathy, 10/2004-05/2006
  52. Takeda 302 and 203 sitagliptin 11/2013-1/2014
  53. Takeda 583 Neuropathy, 09/2006-10/2007
  54. Viaject 06 & 08 J Injectable Insulin (IND # 70,951), 01/2007-01/2010
  55. Welchol 305/306 oral diab. med., 03/2009-2010
  56. Wockhardt insulin, 12/10/2011

Healthcare Communications Group Achievement Award, 2007   Best of Tustin Award, Physicians & Surgeons, 2008

Call the Diabetes Research Center, Tustin, CA
714-734-7944
© University Clinical Investigators, Inc. All Rights Reserved.   Website by JE Web Design.